Jun. 26, 2023 11:48 AM ETRecursion Pharmaceuticals, Inc. (RXRX) In line with the company’s commitment to sustainability, the new building is designed to meet the requirements of the Toronto Green ...
Fintel reports that on July 18, 2023, Needham reiterated coverage of Recursion Pharmaceuticals Inc - (NASDAQ:RXRX) with a Buy recommendation. As of July 6, 2023, the average one-year price target for ...
TORONTO, June 26, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today celebrated the opening of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback